Zymar - Gatifloxacin ophthalmic solution, 0.3% - Allergan - Fluoroquinolone approved for bacterial conjunctivitis

被引：0

|

作者：

不详

机构：

来源：

FORMULARY | 2003年 / 38卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：353 / 353

页数：1

相关论文

共 47 条

[11] Besifloxacin Ophthalmic Suspension, 0.6%: a Novel Topical Fluoroquinolone for Bacterial Conjunctivitis
Terrence P. O’Brien
Advances in Therapy, 2012, 29 : 473 - 490
[12] Besifloxacin Ophthalmic Suspension, 0.6%: a Novel Topical Fluoroquinolone for Bacterial Conjunctivitis
O'Brien, Terrence P.
ADVANCES IN THERAPY, 2012, 29 (06) : 473 - 490
[13] Moxifloxacin 0.5% Ophthalmic Solution In Bacterial Conjunctivitis
Keating, Gillian M.
DRUGS, 2011, 71 (01) : 89 - 99
[14] Efficacy and safety of 0.5% levofloxacin ophthalmic solution (LVFX) compared to 0.3% ofloxacin ophthalmic solution (OFLX) for the treatment of bacterial conjunctivitis.
McCulley, JP
Wapner, FL
Graves, AL
Van Buskirk, AL
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S149 - S149
[15] CIPROFLOXACIN OPHTHALMIC OINTMENT 0.3-PERCENT AS A TREATMENT FOR BACTERIAL CONJUNCTIVITIS
HORWITZ, BL
ABSHIRE, R
SAINZ, DL
SPRINGER, VA
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 935 - 935
[16] Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial (vol 34, pg 250, 2018)
Baiza-Duran, L.
Olvera-Montano, O.
Mercado-Sesma, A. R.
Oregon-Miranda, A. A.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 35 (01) : 76 - 76
[17] Effect of gatifloxacin ophthalmic solution 0.3% on human corneal endothelial cell density and aqueous humor gatifloxacin concentration
Price, MO
Quillin, C
Price, FW
CURRENT EYE RESEARCH, 2005, 30 (07) : 563 - 567
[18] TRIMETHOPRIM-POLYMYXIN OPHTHALMIC SOLUTION VERSUS CHLORAMPHENICOL OPHTHALMIC SOLUTION IN THE TREATMENT OF BACTERIAL CONJUNCTIVITIS
VANRENSBURG, SFJ
GIBSON, JR
HARVEY, SG
BURKE, CA
PHARMATHERAPEUTICA, 1982, 3 (04) : 274 - 277
[19] Azithromycin 1.5% Ophthalmic Solution In Purulent Bacterial or Trachomatous Conjunctivitis
Garnock-Jones, Karly P.
DRUGS, 2012, 72 (03) : 361 - 373
[20] Penetration of gatifloxacin ophthalmic solution 0.3% into aqueous humor of patients undergoing cataract surgery
Chu, Y
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U351 - U351

← 1 2 3 4 5 →